We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+9.86%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$2.45B
AUM Growth
+$411M
Cap. Flow
+$256M
Cap. Flow %
10.46%
Top 10 Hldgs %
15.35%
Holding
416
New
151
Increased
63
Reduced
54
Closed
124

Sector Composition

Rank Sector Weight
1 Industrials 14.23%
2 Financials 11.54%
3 Healthcare 10.97%
4 Consumer Discretionary 7.9%
5 Energy 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASNA
251
PUT
DELISTED
Ascena Retail Group, Inc.
ASNA
$1.2M 0.05%
+3,000
New +$1.07M
ACHC icon
252
Acadia Healthcare
ACHC
$2.94B
$1.14M 0.05%
28,954
-121,046
-81% -$4.49M
FCSC
253
DELISTED
Fibrocell Science Inc.
FCSC
$1.09M 0.04%
+16,667
New +$1.35M
UNXL
254
DELISTED
Uni-Pixel, Inc.
UNXL
$1.09M 0.04%
61,561
-25,000
-29% -$398K
RLJE
255
CALL
DELISTED
RLJ Entertainment, Inc.
RLJE
$1.09M 0.04%
66,667
BLUE
256
DELISTED
bluebird bio
BLUE
$1.08M 0.04%
3,088
+772
+33% +$287K
FUEL
257
DELISTED
Rocket Fuel Inc.
FUEL
$1.07M 0.04%
+20,000
New +$1.13M
OCSI
258
DELISTED
Oaktree Strategic Income Corporation
OCSI
$1.07M 0.04%
+79,100
New +$1.1M
CVT
259
DELISTED
CVENT, INC.
CVT
$978K 0.04%
+27,800
New +$1.01M
MRK icon
260
Merck
MRK
$318B
$952K 0.04%
+20,960
New +$957K
POST icon
261
Post Holdings
POST
$3.57B
$946K 0.04%
35,812
-41,062
-53% -$1.2M
CSTM icon
262
Constellium
CSTM
$3.99B
$940K 0.04%
48,432
-154,168
-76% -$2.8M
DRTX
263
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
$904K 0.04%
+100,000
New +$829K
AGNC icon
264
AGNC Investment
AGNC
$12.9B
$903K 0.04%
+40,000
New +$900K
KBH icon
265
KB Home
KBH
$3.59B
$901K 0.04%
+50,000
New +$875K
AMRE
266
DELISTED
AMREIT INC NEW COM STK
AMRE
$868K 0.04%
+50,000
New +$893K
ENZY
267
DELISTED
Enzymotec Ltd
ENZY
$828K 0.03%
+50,000
New +$868K
HPTX
268
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$820K 0.03%
31,394
-50,000
-61% -$1.25M
BCOV
269
DELISTED
Brightcove, Inc.
BCOV
$753K 0.03%
66,972
-255,000
-79% -$2.57M
RMGN
270
DELISTED
RMG Networks Holding Corporation
RMGN
$751K 0.03%
+25,000
New +$887K
SUPN icon
271
Supernus Pharmaceuticals
SUPN
$2.77B
$733K 0.03%
+100,000
New +$672K
DFRG
272
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$726K 0.03%
+36,022
New +$740K
BIOA
273
CALL
DELISTED
BioAmber Inc.
BIOA
$711K 0.03%
145,000
BIOA
274
DELISTED
BioAmber Inc.
BIOA
$711K 0.03%
145,000
REXR icon
275
Rexford Industrial Realty
REXR
$8.19B
$676K 0.03%
+50,000
New +$686K

Similar funds

Alyeska Investment Group's Q3 2013 Portfolio in Review

As of Q3 2013, Alyeska Investment Group held 416 positions worth $2.45B, up 20% from $2.04B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Alyeska Investment Group deployed $256M of net new capital in Q3 2013, opening 151 new positions and adding to 63 existing holdings. Its largest new stake was Weatherford International plc: 1,850,370 shares worth $28.4M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $29.4M trimmed.

  • Alyeska Investment Group's largest Q3 2013 buy was Weatherford International plc: 1,850,370 shares worth $28.4M.
  • Alyeska Investment Group added most to ITT in Q3 2013, an estimated $19.5M increase.
  • Alyeska Investment Group's biggest Q3 2013 reduction was Meta Platforms (Facebook), cutting an estimated $29.4M.
  • Alyeska Investment Group fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2013, selling an estimated $21.3M.
  • Alyeska Investment Group's ten largest holdings make up 15% of its $2.45B portfolio in Q3 2013.
  • Alyeska Investment Group opened 151 new positions and closed 124 in Q3 2013.
  • Alyeska Investment Group's portfolio value rose 20% quarter-over-quarter to $2.45B.

Based on Alyeska Investment Group's 13F filing for Q3 2013, filed 14 Nov 2013.